Distillate API

Cannabinoid distillate API for licensed formulation programs.

Cannabinoid distillate is a refined oil-based API family used where formulation teams need potency, consistency, and controlled GMP documentation.

GMP API supply

Cannabinoid distillate manufactured for serious formulation and procurement teams.

Refined cannabinoid distillate family for partner programs that require scalable oil-based API inputs and GMP-aligned production controls.

For API buyers, the decision is not simply cannabinoid percentage. The real value is repeatability: controlled inputs, validated pharmaceutical processing, release documentation, and a supplier that understands how the ingredient behaves when it moves from sample approval into commercial formulation.

Useful as a broad API category page for formulation teams comparing distillates against isolates, crude extracts, or finished product manufacturing options.

Buyer value

Why specify Cilo Cybin cannabinoid distillate.

01

GMP Manufacturing

Produced inside a pharmaceutical manufacturing environment where batch records, controlled procedures, and quality review form part of the supply conversation.

02

Analytical Confidence

Assay, cannabinoid profile, residual solvent profile, traceability from source material, batch records, and release documentation.

03

Formulation Utility

Oils, tinctures, capsules, edible bases, topical products, vape formats, and client-defined formats where legally permitted.

04

Process Knowledge

Viscosity, carrier selection, dosing accuracy, heat exposure, packaging compatibility, and destination-market documentation should be confirmed early.

Distillation and refinement

Cannabinoid distillate with specification-led release.

Viscous refined oil, with final cannabinoid profile and strength defined by the selected input, process route, and batch release specification. The ingredient should be assessed against the buyer's intended product format, target concentration, carrier system, packaging, and destination-market rules.

Cilo Cybin's API positioning is built around pharmaceutical discipline: qualified source material, controlled processing, in-process accountability, batch release review, and documentation that supports partner due diligence.

For commercial procurement, the discussion should cover certificate of analysis, identity and assay, purity profile, related cannabinoids, residual solvent controls, storage conditions, retest or expiry expectations, and container closure suitability.

API familyCannabinoid distillate
API formatRefined oil
Primary fitScalable formulation input
Supply routeLicensed programs

Procurement checklist

Questions to settle before ordering cannabinoid distillate.

01

Specification

What assay range, impurity limits, physical format, and release criteria are required for the finished product dossier or internal quality system?

02

Compatibility

Will the API be used in oil, capsule, edible, topical, vape, compounding, or another licensed format, and what excipients or processing conditions will it meet?

03

Documentation

Which batch records, COA fields, traceability records, packaging details, and regulatory documents are required by the receiving license holder?

04

Scale

Does the buyer need R&D sample material, pilot quantities, repeat commercial supply, or a specification development pathway before larger-volume procurement?

Related API's

Compare related cannabinoid ingredients.

API

API Overview

Review format, specification, and formulation considerations for this related API.

API

THC Distillate

Review format, specification, and formulation considerations for this related API.

API

CBD Distillate

Review format, specification, and formulation considerations for this related API.

API

CBD Isolate

Review format, specification, and formulation considerations for this related API.

Cilo Cybin enquiry

Discuss cannabinoid manufacturing, product development, or supply requirements.

Contact the Cilo Cybin team to discuss API supply, contract manufacturing, product development, governance, or listed-company enquiries.